Company intelligence / Profile preview

Zimbrine Holding

Amsterdam, Netherlands

Ownership: Private
Development stage: Other

Overview

Zimbrine Holding B.V. is a Netherlands-based investment holding company that serves as a primary investment vehicle for the prominent Swedish entrepreneur and investor Staffan Persson. The company is a significant stakeholder in the Nordic life sciences and technology sectors, having held substantial positions in firms such as Moberg Pharma, Accelerator Nordic, and Boule Diagnostics. Zimbrine Holding provides strategic capital and oversight to its portfolio companies, focusing on long-term value creation in specialty pharmaceuticals, diagnostics, and digital services. It is closely associated with Swedia Capital, the broader investment firm managed by Staffan Persson.

Industry: Investors

Beyond the preview

Go deeper on Zimbrine Holding.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zimbrine Holding.

Explore the full profile